Puretech Health PLC Logo

Puretech Health PLC

PRTC | IL

Overview

Corporate Details

ISIN(s):
GB00BPVG5C82 (+2 more)
LEI:
213800LVPDNO2Z9T9I39
Country:
United States of America
Address:
6 TIDE STREET, 02210 BOSTON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Puretech Health PLC is a cutting-edge biotechnology company that is focused on developing and commercializing a wide range of innovative therapies in the healthcare industry. The company is based in the United Kingdom, and it has a growing presence in key markets around the world. Puretech Health is dedicated to leveraging the latest scientific advances to create transformative medicines that improve human health and wellness. The company works closely with leading researchers, academic institutions, and industry partners to develop novel approaches to treating a wide range of medical conditions.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Puretech Health PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-04 18:30
Major Shareholding Notification
Holding(s) in Company
English 25.0 KB
2025-08-21 13:00
Regulatory News Service
PureTech Showcases Differentiated IPF Strategy
English 34.6 KB
2025-08-18 08:00
Report Publication Announcement
Notice of Results
English 8.8 KB
2025-08-13 18:12
Regulatory News Service
PRTC's Vedanta Announces VE202 Phase 2 Results
English 23.1 KB
2025-08-12 13:00
Business and Financial Review
PRTC Launches Celea to Advance Ph3-Ready IPF Drug
English 22.0 KB
2025-08-05 18:30
Major Shareholding Notification
Holding(s) in Company
English 22.1 KB
2025-08-01 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 9.8 KB
2025-07-17 13:05
Regulatory News Service
PRTC’s Seaport Begins Phase 2b Study in MDD
English 27.4 KB
2025-07-16 08:00
Board/Management Information
PureTech Announces Leadership Transition
English 13.9 KB
2025-07-04 18:30
Director's Dealing
PDMR Notification
English 22.3 KB
2025-07-04 18:30
Director's Dealing
PDMR Notification RSU Vesting
English 24.5 KB
2025-07-04 18:30
Remuneration Information
PDMR Notification RSU Vesting
English 24.0 KB
2025-06-16 18:27
Post-Annual General Meeting Information
Result of AGM
English 32.0 KB
2025-05-29 18:30
Major Shareholding Notification
Holding(s) in Company
English 25.0 KB
2025-04-30 16:27
Proxy Solicitation & Information Statement
Proxy Form for 2025 AGM
English 219.2 KB

Automate Your Workflow. Get a real-time feed of all Puretech Health PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Puretech Health PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN